There were 2,460 press releases posted in the last 24 hours and 441,515 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image